Antti Lauerma Selected Research

Antti Lauerma Research Topics

Disease

15	Inflammation (Inflammations) 06/2022 - 04/2003
11	Atopic Dermatitis (Atopic Eczema) 01/2022 - 11/2004
10	Contact Dermatitis (Eczema, Contact) 01/2022 - 04/2003
10	Hypersensitivity (Allergy) 11/2021 - 04/2003
8	Asthma (Bronchial Asthma) 10/2021 - 12/2009
3	Skin Diseases (Skin Disease) 01/2022 - 01/2005
3	Allergic Contact Dermatitis 01/2021 - 10/2007
3	Acne Vulgaris 01/2018 - 01/2014
2	Infections 01/2022 - 12/2010
2	Dysbiosis 10/2019 - 01/2014
2	Latex Hypersensitivity (Latex Allergy) 05/2011 - 04/2003
2	Dermatitis 12/2005 - 04/2003
1	COVID-19 11/2021
1	Anaphylaxis (Anaphylactic Shock) 10/2021
1	Allergic Rhinitis 10/2021
1	Premature Birth (Birth, Premature) 10/2017
1	Neonatal Sepsis 10/2017
1	Birth Weight (Birth Weights) 10/2017
1	Lymphoma (Lymphomas) 06/2017
1	Virus Diseases (Viral Diseases) 05/2012
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 05/2011
1	Pneumonia (Pneumonitis) 05/2011
1	Bronchial Hyperreactivity 05/2011
1	Wounds and Injuries (Trauma) 12/2010
1	Lymphadenopathy 01/2010
1	Urticaria (Hives) 11/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2007
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2005
1	Cutaneous Lupus Erythematosus 04/2005

Drug/Important Bio-Agent (IBA)

12	AllergensIBA 10/2014 - 11/2004
7	CytokinesIBA 10/2021 - 01/2010
5	Immunoglobulin E (IgE)IBA 04/2013 - 04/2003
4	Irritants (Vesicants)IBA 01/2022 - 10/2007
3	Filaggrin ProteinsIBA 06/2022 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2019
3	AntibodiesIBA 04/2013 - 04/2003
3	Proteins (Proteins, Gene)FDA Link 04/2010 - 04/2003
3	ChemokinesIBA 01/2010 - 11/2004
3	SuperantigensIBA 01/2007 - 11/2004
2	NickelIBA 01/2021 - 10/2014
2	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2010
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2010
2	Isotretinoin (Accutane)FDA LinkGeneric 01/2018 - 01/2016
2	Interleukin-33IBA 11/2013 - 05/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2013 - 12/2010
2	LigandsIBA 04/2013 - 11/2004
2	HaptensIBA 01/2012 - 10/2007
2	OxazoloneIBA 01/2012 - 12/2010
2	LatexIBA 05/2011 - 04/2003
2	Rubber (Elastica)IBA 05/2011 - 04/2003
2	staphylococcal enterotoxin BIBA 12/2005 - 11/2004
2	CC ChemokinesIBA 04/2005 - 11/2004
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	VenomsIBA 11/2021
1	COVID-19 VaccinesIBA 10/2021
1	Tryptophan (L-Tryptophan)FDA Link 10/2019
1	LymecyclineIBA 01/2018
1	RetinoidsIBA 01/2018
1	16S Ribosomal RNAIBA 01/2018
1	TetracyclinesIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	Enterotoxins (Enterotoxin)IBA 06/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	LipopolysaccharidesIBA 04/2013
1	N- palmitoyl- S- (2,3- bis(palmitoyloxy)propyl)cysteinyl- seryl- lysyl- lysyl- lysyl- lysineIBA 04/2013
1	VaccinesIBA 11/2012
1	Phosphates (Orthophosphate)IBA 05/2011
1	GuanosineIBA 05/2011
1	CytosineIBA 05/2011
1	Methacholine Chloride (Methacholine)FDA Link 05/2011
1	CosmeticsIBA 01/2011
1	Interferon Type IIBA 12/2010
1	Nucleic AcidsIBA 12/2010
1	Peptides (Polypeptides)IBA 12/2010
1	CathelicidinsIBA 12/2010
1	CTLA-4 AntigenIBA 09/2010
1	trimellitic anhydrideIBA 01/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2010
1	Chemokine ReceptorsIBA 01/2010
1	Immunoglobulin G (IgG)IBA 12/2005
1	AcidsIBA 01/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2005

Therapy/Procedure

4	Therapeutics 11/2019 - 01/2014
2	Injections 10/2021 - 05/2011
1	Precision Medicine 11/2019
1	Neonatal Intensive Care 10/2017